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Several reports have indicated that cortical resection is effective in alleviating intractable epilepsy in children with tu- 
berous sclerosis complex (TSC). Because of the multitude of cortical lesions, however, identifying the epileptogenic 
tuber(s) is difficult and often requires invasive intracranial electroencephalographic (EEG) monitoring. As increased 
concentrations of serotonin and serotonin-immunoreactive processes have been reported in resected human epileptic 
cortex, we used a-["C]methyl- tryptophan (["CIAMT) positron emission tomography (PET) to test the hypothesis that 
serotonin synthesis is increased interictally in epileptogenic tubers in patients with TSC. Nine children with TSC and 
epilepsy, aged 1 to 9 years (mean, 4 years 1 month), were studied. All children underwent scalp video-EEG monitoring, 
PET scans of glucose metabolism and serotonin synthesis, and EEG monitoring during both PET studies. ["CIAMT 
scans were coregistered with magnetic resonance imaging and with glucose metabolism scans. Whereas glucose metabo- 
lism PET showed multifocal cortical hypometabolism corresponding to the locations of tubers in all 9 children, 
["CIAMT uptake was increased in one tuber (n = 3), two tubers (n = 3), three tubers (n = l), and four tubers 
(n = 1) in 8 of the 9 children. All other tubers showed decreased ["CIAMT uptake. Ictal EEG data available in 8 
children showed seizure onset corresponding to foci of increased ["CIAMT uptake in 4 children (including 2 with 
intracranial EEG recordings). In 2 children, ictal EEG was nonlocalizing, and in 1 child there was discordance between 
the region of increased ["CIAMT uptake and the region of ictal onset on EEG. The only child whose ["CIAMT scan 
showed no regions of increased uptake had a left frontal seizure focus on EEG; however, at the time of his ["CIAMT 
PET scan, his seizures had come under control. ["CIAMT PET may be a powerful tool in differentiating between 
epileptogenic and nonepileptogenic tubers in patients with TSC. 
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Tuberous sclerosis complex (TSC) is an autosomal 
dominant inherited disorder with a high spontaneous 
mutation rate, now known to result from mutations in 
at least two different genes, TSC1',2 and TSC13 
These genetic mutations result in tumorous growths in 
multiple organs, including the brain, skin, heart, and 
kidney.425 More than 80% of children with TSC have 
epilepsy due to brain cortical lesions, and for many of 
these children, the seizures cannot be adequately con- 
trolled by  medication.*^" Although surgical resection of 
the epileptic focus (consisting of tuber and surrounding 
epileptogenic tissue) is now being performed to allevi- 
ate the intractable epilepsy in children with TSC,'-''' 
currently available noninvasive methods do not ade- 
quately identify the epileptogenic tuber(s) amid the 
multiple cortical lesions typical in these patients. As a 
result, the preoperative evaluation usually includes 
chronic intracranial electrographic monitoring, which 
is both invasive and expensive. Clearly, a neuroimaging 
method that is capable of differentiating between epi- 
leptogenic and nonepileptogenic lesions interictally 
would represent an important advance in the surgical 
management of children with 'TSC." 
Because increased serotonin (5HT) and 
imrnunorea~tivity'~ has been reported in human epi- 
leptic tissue removed for seizure control, we applied 
positron emission tomography (PET) with the new 
tracer a-["C]methyl-~-tryptophan (["CIAMT) in 
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children with TSC a n d  epilepsy. This  method is de- 
signed to  measure 5HT synthesis in vivo,'5-'8 as the  
intravenously injected ["CIAMT is converted in the 
brain to a_[' ' Clmethyl-5HT ([' 'CIAM-SHT), which 
is no t  a substrate for the enzyme monoamine oxidase'' 
and, therefore, accumulates in serotonergic terminals. 
Patients and Methods 
Patients 
Nine children with TSC and epilepsy were studied. All met 
the established diagnostic criteria for TSC.' There were 5 
males and 4 females, aged 1 year 1 month to 9 years 2 
months, with a mean age of 4 years 1 month (Table 1). 
Studies were performed in compliance with regulations of 
Wayne State University Human Investigation and Radiation 
Drug Research Committees, and informed consent of parent 
or guardian was obtained before all ["CIAMT PET scans. 
Continuous video-electroencephalographic (video-EEG) 
monitoring was performed to determine the location(s) of 
seizure onset as a component of the clinical evaluation to 
determine eligibility for cortical resection. The International 
10-20 system for electrode placements was used, and record- 
ings were made on a Biomedical Monitoring Systems 
(Campbell, CA) 64-channel tape system. Also included in 
the clinical evaluation were computed tomography, magnetic 
resonance imaging (MRI), and PET scanning of brain glu- 
cose metabolism, using the tracer 2-dco~y-2-['~F]fluoro-~- 
glucose ([I8F]FDG). 
[" CIAMT Synthesis and Dosimetry 
The ["CIAMT was produced by using a synthesis module 
designed and built in-house, capable of manipulating the 
necessary chemistry remotely, using radioactive precursor in- 
side the hot ce11.20.2' Human organ activity and residence 
time were estimated as previously described." Final values of 
radiation dose estimates were calculated by using the resi- 
dence time estimates and the MIRDOSE programs (IBM 
PC, version 3.0, November 1994) for children of different 
ages.22 The dose of ["CIAMT for PET studies in children 
was 0.1 mCi/kg. 
PET Scanning Protocols 
The ["FIFDG and ["CIAMT PET scans were performed 
on different days. The procedure for [I8F]FDG PET scan- 
ning has been described p r e v i o ~ s l y . ~ ~  For the ["CIAMT 
PET scan, subjects were fasted for 6 hours to obtain stable 
plasma tryptophan and large neutral amino acid levels during 
the course of the study. Two venous lines were established, 
one for tracer injection and one for collection of timed blood 
samples (0.5 mllsample, collected at 0, 20, 30, 40, 50, and 
60 minutes after ["CIAMT injection); plasma tryptophan 
concentration was measured in these samples by high- 
pressure liquid chromatography as previously described.24325 
Fiduciary markers containing 0.25 FCi ["CIAMTlmCi in- 
jected were placed on the scalp to allow for correction of 
motion, if necessary. Heart rate, blood pressure, and pulse 
oximetry were measured periodically during the study, and 
the scalp EEG was monitored continuously. The children 
were sedated intravenously with either nembutal (5 mg/kg 
intravenously) or midazolam (0.2- 0.4 mg/kg intravenously). 
Prior studies performed in our laboratory on 5 adult volun- 
teers each scanned twice (once without and once with seda- 
tion by using midazolam) have found differences of less than 
10% in 5HT synthesis between the two testing conditions 
(in preparation); these differences are within the accepted 
tesdretest range for PET tracers.2h 
The ["CIAMT (0.1 mCi/kg) was injected intravenously 
as a slow bolus over 2 minutes. Twenty-five minutes after 
tracer injection, a dynamic emission scan of the brain (7 X 5 
minutes) was acquired in three-dimensional (3D) mode. 
PET studies were performed by using the CTUSiemens 
EXACT/HR whole-body positron tomograph (Knoxville, 
TN). Measured attenuation and decay correction was applied 
to all images. 
PET Data Processing and Data Analysis 
The standardized uptake value (SUV) method for semiquan- 
titative analysis of tracer accumulation was The 
SUV represents tissue activity concentration normalized to 
the injected activity per kilogram of body weight. PET im- 
ages from time frames 2 to 5 (best image quality) were 
summed and calibrated to microcuries per cubic centimeter 
(pCi/cc), representing the retention of [ '  'CIAMT from 30 
to 50 minutes after tracer injection. As all subjects received a 
standardized dose based on their weight (0.1 mCi/kg), cali- 
brated images directly depict the S U V  value.18 ["CIAMT 
PET scans were coregistered with MRI and ["FIFDG PET 
scans by using a multipurpose 3D registration technique 
(MPItool) developed at the Max-Planck-Institute.2".'0 Foci 
of increased and decreased ["CIAMT uptake were matched 
with the locations of tubers identified on MRI and 
[18F]FDG PET scans. Regions of interest were drawn man- 
ually around tubers with increased and decreased [ '  'CIAMT 
uptake and around the surrounding cortex. The average S U V  
for regions of interest was determined as a weighted average 
over all planes showing the region. Values for tubers with 
increased ["CIAMT uptake were compared with regions of 
surrounding cortex and with tubers with decreased 
["CIAMT uptake by using a matched-pairs t test (two- 
tailed, with Bonferroni correction). 
T o  facilitate the anatomical localization of increased 
["CIAMT uptake in Patient 1 in relation to the location of 
intracranial electrodes on the brain surface, coregistered 
["CIAMT PET and MRI volumes were surface rendered by 
using the Phong illumination model3' provided by the 
MEDx software (Senson Systems, Sterling, VA). In brief, 
given a 3D volume and a surface constant value, the algo- 
rithm determines the vertices of all surface polygons and sur- 
face normals.32 These data were then used with the Phong 
shading algorithm" to create a shaded surface of the brain 
cortex. Both PET and MRI image volumes were 3D-surface 
rendered, using identical viewing parameters, and the area of 
increased ["CIAMT uptake was localized on the PET sur- 
face, using a maximum intensity projection. O n  the MRI 
scan, the position of the grid electrode array on the cortical 
surface could be recognized due to the small distortions of 
the magnetic field in the vicinity of the metal electrodes. Fi- 
nally, the outline of the PET abnormality was transferred to 
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Table 1. Selected Patient Dutu 
Patient No./ 
SexlAge at AMT-PET (Medications 




yr 2 mo 
3ifemalei2 















At 1 wk, c h i c  seizures; at 5 
mo, infantile spasms; ronic- 
clonic seizures began at 5 yr; 
also complex partial seizures; 
both seizure types intractable 
(12-14 tonic-chic  seizures/ 
Nonambulatory, nonverbal, se- 
day) 
vere developmental delay, 
and severe L hemiparesis 
Onset of infantile spasms at 4.5 
mo; now has complex partial 
seizures and tonic seizures 
Developing normally, with L 
peripheral visual field deficit 
At 6 wk, complex partial sei- 
zures with eyes to L, and 
vocalizations; at 5 mo, myo- 
clonic jerks; at 7 mo, infan- 
tile spasms. 
At present, ronic-clonic seizures 
(L > R involvement), 20- 
4O/day, also complex partial 
seizures, mild developmental 
delay, and subtle L hemiparesis 
At 5 wk, onset of seizures with 
L arm flexion; now stares 
and verbalizes during sei- 
zures; mild L hemiparesis 
and mild cognitive delay 
At 4 nio, infantile spasms; now 
tonic-clonic seizures followed 
by clusters of head drops; 
also has complex partial 
seizures 
Onset of complex partial sei- 
zures at 1.5 yr2 now has fre- 
quent secondary generaliza- 
tion; behavioral disorder and 
autistic; mother and her 2 
sisters have TSC 
day of age; at 4 mo, infantile 
spasms; now tonic seizures, 
sometimes preceded by a 
head drop; no speech, 
nonambulatory. and L 
handed 
Onset of clonic seizures at 1 
At 2.5 mo, complex partial sei- 
zures; at 3 mo, intiantile 
spasms; seiures now reason- 
ably well controlled with 
occasional breakthrough of 
spasms; mild right-hand 
weakness 
Age 4 mo, onset of infantile 
spasms, responded to vigaba- 
trin; seizure free until 1 yr 4 
nio when developed complex 
partial seizures, now con- 
trolled; slight speech delay, 
otherwise developing nor- 
mally; normal exam 
Increased uptake in single 
large R posterior fron- 
tal, parietal, superior 
temporal tuber; all 
other tubers showed 
decreased uptake (lam- 
otrigine and vigabarrin) 
Multifocal independent 
epileptiform activity, 
especially R parietal, 
central, and temporal 
Increased uptake in R Active R occipital 
frontal and R occipital spiking 
tubers; decreased uptake 
in all other tubers (phe- 
nobarbital, carbamaze- 
pine, and topiramate) 
Increased uptake in R su- Multifocal independent 
petior posterior frontal epileptiform acriviry 
tuber adjacent to previ- with R central tem- 
ous resection, and in poral predominance 
anorher tuber in R infe- 
rior frontal cortex; all 
other tubers showed 
decreased uptake 
(carbamazpine) 
Increased uptake in R su- 
perior frontal tuber and 
R inferior frontal tilber; 
all other tubers showed 
decreased uptake 
(vigabatrin) 
Increased uptake in R pos- 
terior temporal tuber; 
all other tubers showed 
decreased uptake 
(valproare) 
Increased uptake in L me- 
dial parietal tuber; all 
other tubers showed 
decreased uptake 
(valproate) 
Increased uptake in R pos- 
terior frontal tuber, R 
inferior frontal tuber, 
and R posterior tempo- 
ral tuber; all other tu- 
bers show decreased 
uptake (vigabatrin, clo- 
nazepam, phenobarbital, 
and ketogenic diet) 
1st scan, increased uptake 
of tuber in R temporal 
pole (carbamazepine 
and vigabarrin); 2nd 
scan, increased uptake 
of tubers in R temporal 
pole, R inferior frontal 
correx, and 2 in R pari- 
etal cortex (carbamare- 
pine, vigabatrin, and 
nitrazepam) 
All tubers show decrcased 
uptake (vigabatrin and 
carbamazepine); this 
child's seizures had 
come under control at 
the time of the scan 
Multifocal independent 
epileptiforrn activity 
especially L frontal, 
L central, and R 
temporal 
Generallzed polyphasic 
spike and wave activ- 
ity and indepen- 





prominent L parietal 





especially F,, T,, 
and T, 
Independent frontal 
sharp waves; general- 
ized spike and slow 
wave bursts during 
sleep with L 
predominance 
~ 
AMT-PET = positron emission tomography (PET) with rracer a-["C] methyl-L-tryptophan (AMT); EEG = 
sclerosis complex. 
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Onset R parietal- Ar 8 yr 2 mo, surgical resection of 
tuber and surrounding cortical rim 
showing increased AMT uptake; 
subdural electrodes placed; nor a 
single seizure since surgery (4 mo), 
more alert and interactive, no 
change in L hemiparesis 
temporal 





graphic onset by 
20 sec 
seizures 
R frontal onset of 
Right frontal onset 
at F, and FP, 
Being evaluated for epilepsy surgery 
At 2 yr at another institution, partial 
resection of R frontal tuber fol- 
lowing subdural electrodes, shoul- 
der area of motor cortex involved, 
but not resected; seizures contin- 
ued; at 3 yr 3 mo, at another (dif- 
ferent) institution, further resec- 
tion of tuber with increased AMT 
uptake; resection limited because 
of proximity to motor cortex; 
tonic-clonic seizures subsided, 
complex partial seizures continued 
Considering epilepsy surgery 
Right hemisphere Considering epilepsy surgery 
onset, could not 
be further 
localized 
Not done Not actively being pursued 
L frontal onset of Not  being considered 
seizures 
Onset could not be Not  being considered 
localized or 
lateralized 
Onset L frontal Nor being considered 
(F,) 
electroencephalography; L = left; R = right; TSC = tuberous 
Fig I .  Positron emission tomographic (PEr) scans in a 
2-year-old boy (Patient 4) with tuberous sclerosis complex and 
intractable epilepsy. (A) The 2-de0xy-2-[~~F]~uoro-~-glucose 
PET scan shows multiple regions o f  cortical hypometabolism 
corresponding to the location of tubers (arrows). (B) 
a-[" C]methyl-~-tryptophan ([I' CJAMT) standardized uptake 
value (Sw images display multiple regions o f  decreased 
tracer uptake in the location of tubers compared with nonle- 
rional cortex (thin arrows). Two regions in right fiontal cor- 
tex display a large increase in ["C]AMT uptake with a nod- 
ular distribution (bold arrows). ~deo-electroencephalographic 
monitoring of seizures revealed the right fiontal lobe to be the 
region 5f ictal onset. The l e ?  side of the image is the right 
side of the brain. 
the MRI surface, to determine the location of the PET ab- 
normality relative to the location of electrodes overlying re- 
gions of ictal onset. 
Results 
The findings on [llC]AMT PET scans, as well as in- 
terictal and ictal EEG, are summarized in Table 1. 
[18F]FDG PET images revealed multiple foci of de- 
creased glucose metabolism in cortical regions corre- 
sponding to locations of tubers (Figs 1-3); these results 
are consistent with previous reports.' 1,33 Examination 
of the [llC]AMT S U V  images also showed multiple 
foci of reduced tracer uptake compared with surround- 
ing cortex; however, there were also focal regions of 
increased tracer uptake in the cortex. Ratios of S W s  
for tubers with increased [l'C]AMT uptake to sur- 
rounding cortex and tubers with low ["CIAMT are 
shown in Table 2. Three children showed one region 
of increased uptake (see Fig 3 ) ,  another 3 children 
showed two regions (see Figs 1 and 2), and 1 subject 
each showed three and four regions of increased 
["CIAMT uptake (see Tables 1 and 2). The magni- 
tude of focal increase relative to adjacent cortex ranged 
from 5 to I1  1% (25 ? 25%, mean 2 SD; p = 0.01). 
SUV values in tubers with increased [' ' CIAMT uptake 
were 20 to 188% (61 t 449'0, mean t SD; p = 
0.003) higher than in tubers with low uptake from the 
same subject. 
Eight of the 9 children have undergone scalp video- 
EEG monitoring to localize seizure onset for potential 
cortical resection. One of these (Patient 9) had a left 
frontal seizure focus, but his seizures were controlled at 
the time of [llC]AMT PET, which did not show any 
regions of increased ["CIAMT uptake. Of the remain- 
ing 7 children who had undergone video-EEG moni- 
toring, 4 showed excellent correspondence between sei- 
zure foci and regions of increased ["CIAMT uptake 
(Patients 1 through 4) ,  but there was poor correspon- 
dence in 1 child (Patient 7). In 2 children (Patients 5 
and 8), ictal EEG recordings failed to localize the sei- 
zure foci; however, in I of these (Patient 5 ) ,  the ictal 
EEG lateralized seizure onset to the same hemisphere 
as the focus of increased [llC]AMT uptake. Patient 8 
was studied twice with ["CIAMT PET; at 3 months, 
~ ~ ~ ~~ ~~ 
Fig 2. Positron emission tomographic (PEr) scans in a 
2-year-old girl (Patient 3) with tuberous sclerosis complex and 
intractable epiLep.y. (A) The 2-de0~-2-('~F]flztoro-n-glu~0~e 
PET scan shows multiple regions o f  cortical hypometabolism 
corresponding to the location of tubers (arrows). (B) The 
a-[" C]methyl-~-tryptophan (['I CJAMT) standardized uptake 
value PET scans show a nodular region of increased 
["C]MT uptake in the right fiontalhntral region (bold 
arrow). In addition, there is a region of increased ["C]AMT 
uptake of smaller magnitude surrounding a tuber in the right 
inferior fiontal lobe (bold arrow). Thin arrows denote tubers 
with decreased ["C]MT uptake. The lefi side o f  the image is 
the right side of the brain. 
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Fig 3. Magnetic resonance imaging (MH) and positron emission tomographic (PEr) scans in an 8;vear-old girl (Patient 1) with 
tuberous sclerosis complex and intractable epilepsy. (A) MRI scan showing large tuber in the right central/parietal region (bold ar- 
row) as well as other smdller lesions (thin arrows). (B) The glucose metabolism PET scan shows cortical hypometabolism in the 
same regions as the lesions seen on MRI (arrows). (C) a-[" C]methyl-~-tryptophan ( [ I 1  CIAMT) standardized uptake value images 
display decreased tracer uptake in the location of small tubers compared with adjacent nonlesional cortex (thin arrow). The large right 
central tuber (bold arrow) shows a 110% increase in [ " C ] M T  uptake. The leJt side of the image is the right side ofthe brain. 
Table 2. Ratios o f  S W s  for Tubers with Increased 
["C]AMT Uptake to Adjacent Cortex and to Tubers with 
Low ["CJAMT Uptake 
Tuber/ 
Patient Tuber/ Other 




R superior frontal 
R inferior frontal 
R superior frontal 
R inferior frontal 
R temporal 
L parietal 
R posterior frontal 
R inferior frontal 
R posterior temporal 
R temporal 




















Mean 1.250 1.618 
Standard 0.255 0.439 
deviation 
S U V  = standardized uptake value; ["CIAMT = a-["C]methyl-~- 
tryptophan. 
he showed a single focus of increased ["CIAMT up- 
take, but at 1 year 1 month he showed three additional 
foci of increased ["CIAMT uptake in the vicinity of 
the first focus (see Table 1). 
To date, 2 of the children (Patients 1 and 3) have 
undergone surgical resection of the ["CIAMT focus. 
Their results are summarized in Table 1. In Patient 1, 
intracranial subdural grid electrode arrays were placed 
on posterior frontal, parietal, and temporal cortex for 
more precise localization of ictal onset before resective 
surgery. A volumetric MRI scan acquired with sub- 
dural electrodes in place was coregistered with the 
[llC]AMT PET scan, and both MRI and PET scans 
underwent a maximum intensity projection in 3D. The 
region of increased [ "CIAMT uptake was delineated 
and superimposed on the MRI showing the position of 
the subdural electrodes (Fig 4). During the intracranial 
monitoring period, the patient had 10 of her typical 
seizures. Eight of these seizures originated at electrodes 
at the posterior border of the ["CIAMT PET abnor- 
mality (Fig 5A), but the remaining two could not be 
localized. The eight seizures showed rapid spread to the 
anterior and inferior borders of the [llC]AMT PET 
abnormality (see Fig 5B). 
Discussion 
Methodological Issues 
In the present study, the S W  method was applied, 
because these images are of higher quality than para- 
metric images with [11C]AMT,17'18 facilitating the lo- 
calization of focal abnormalities. The S W  m e t h ~ d ~ ' , ~ ~  
is a semiquantitative method, widely used in assessing 
metabolic activity in tumors by using ["FIFDG 
because absolute values of the glucose meta- 
bolic rate are difficult to obtain due to several un- 
known variables in tumors, including the lumped con- 
stant, a factor explaining differences between the 
kinetics of tracer and natural substrate. Likewise, the 
lumped constant for [llC]AMT in humans is un- 
known, and appears to be species specif i~.~" '~ The 
SUV in various regions of brain is equal to the sum o f  
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Fig 4. Magnetic resonance imaging three-dimensional ren- 
dered image (Patient I), using a maximum intensity projec- 
tion showing location of subdural grid electrode placement and 
delineation of region of increased a-[" C]methyl-~-ryptophan 
(['I C]AMT) uptake. The position of the grid electrode array 
on top o f  the exposed cortical suvface can be recognized due to 
the small distortions o f  the magneticjeld in the vicinity of the 
metal electrodes. The circular line delineates the region of in- 
creased [" C]AMT uptake in the fiontoparietal region. 
the precursor ["CIAMT and the metabolic product 
["CIAM-5HT synthesized in these regions. We have 
previously reported an excellent correlation between re- 
gional values of the unidirectional uptake rate constant 
K and regional SUV.18 In another neurological disor- 
der of childhood (ie, autism), we have established that 
the S U V  analytic approach is sensitive in depicting fo- 
cal abn~rmalities.~' 
Epilepsy and Neuroimaging in TSC 
Intracranial lesions in TSC include cortical tu- 
ber~,"-~'  subependymal nodules, subependymal giant 
cell a s t r ~ c y t o m a , ~ ~  and microscopic abnormalities such 
as microdysgenesis, heterotopic gray matter, and lami- 
nation  defect^.^"^^ More than 80% of patients with 
TSC have seizures, and when these are uncontrolled, 
the prognosis is poor for normal cognitive 
Recent attempts at  surgical removal of the epilepto- 
genic tuber(s) have met with some ~ u c c e s s , ~ - ~ ~  but the 
preoperative evaluation is generally invasive due to the 
frequent requirement of intracranial EEG monitoring 
with subdural electrodes. Scalp EEG localization may 
identify the lobe in which seizures are generated; how- 
ever, this lobe may contain multiple tubers, only one of 
which may be responsible for the seizures. Anatomical 
neuroimaging with computed tomography and MRI 
may demonstrate precisely the locations of tubers and 
 calcification^^^ ~ 48 but does not differentiate between 
epileptogenic and nonepileptogenic zones in the brain. 
Even currently available functional imaging studies are 
of limited use in patients with TSC. PET scanning 
with [ "FIFDG shows decreased glucose metabolism 
corresponding to the locations of tubers and calcifica- 
t i o n ~ " ' ~ ~  but is not capable of distinguishing between 
epileptogenic and nonepileptogenic lesions, unless a 
prolonged seizure fortuitously occurs during the tracer 
uptake period, leading to focally increased glucose me- 
tabolism (ictal PET Because of the short half- 
lives of PET isotopes, however, ictal PET studies are 
not practical. Although ictal studies by using single- 
photon emission computed tomography (SPECT) have 
enjoyed more success in this regard, these are particu- 
larly difficult to accomplish in children with TSC, 
whose seizures are typically short lasting and are not 
ideal for ictal SPECT study. Because of this, and its 
relatively poor spatial resolution, SPECT has not been 
applied routinely in the presurgical evaluation of pa- 
tients with TSC and intractable epilepsy. 
The development of a specific PET probe capable of 
differentiating between epileptogenic and nonepilepto- 
genic tubers is an important advance in the neurolog- 
ical management of patients with TSC and intractable 
epilepsy. Our laboratory has been attempting to de- 
velop such a probe for several years. Our initial efforts 
with [' lC]flumazenil PET to measure benzodiazepine 
receptor binding in patients with TSC have not been 
successful in this regard, showing decreased receptor 
binding in all tubers and calcified regions, with no 
specificity for epileptogenicity (Chugani and col- 
leagues, unpublished data). The present findings with 
["CIAMT PET in patients with TSC and uncon- 
trolled seizures strongly suggest that epileptogenic tu- 
bers (characterized by high ["CIAMT uptake) can be 
differentiated from nonepileptogenic ones (character- 
ized by low ["CIAMT uptake). Coregistration of the 
["CIAMT PET images with MRI (see Figs 3 and 4 )  
provides the necessary accurate spatial localization of 
the cortical lesions with high ["CIAMT uptake, which 
appear to correspond to EEG localization of seizure 
onset. Although subependymal lesions were present in 
all 9 children, none of these lesions could be visualized 
on the ["CIAMT PET scans, consistent with the no- 
tion that subependymal lesions are not epileptogenic. 
At present, only 2 of the 9 children studied have 
undergone surgical resection of the lesion showing in- 
creased ["CIAMT uptake (Patient 3 underwent sur- 
gery at another institution), and another 3 children are 
being considered for surgery. Both of the resections 
performed were guided by corticographic recordings 
from subdural electrodes, which showed excellent cor- 
respondence between seizure onset and [ "CIAMT foci 
(see Table I ,  Figs 4 and 5). It is unfortunate that a 
larger resection could not be performed in Patient 3 
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Fig 5. Subdural electroencephalographic recording (Patient 1) showing ictal onset a t  electrodes 58 and 59, which were located at 
the posterior border o f  the tuber, with increased a-["Cjmethyl-~-t~yptophan uptake (A) and spread of seizure to electrodes 8 and 
I 6  around the border of  the tuber (B) (referential recording refirence is inactive electrode 1). 
because of the proximity of the seizure focus to pri- 
mary motor cortex. 
The findings in Patient 2 are interesting and deserve 
some comment. Both interictal and ictal EEG in this 
child suggested a right occipital focus, but clinical on- 
set of each seizure preceded electrographic onset by 20 
seconds or more. ["CIAMT uptake was increased, as 
expected, in a right occipital tuber, bur a second tuber 
in the right frontal cortex also showed increased up- 
take. The significance of this finding is not clear at 
present but may suggest that at least some of the sei- 
zures may have their onset in the right frontal lobe. A 
discussion of Patient 7, in whom ictal EEG and 
["CIAMT PET appear to be discordant, is warranted. 
The magnitude of the increased ["CIAMT uptake in 
right cortical regions of Patient 7 was not as large as 
measured in most subjects (see Table 2). Therefore, 
perhaps only tubers with larger increases of [ '  'CIAMT 
uptake might be reliable in the designation of epilep- 
togenic tubers. It is also possible, however, that the 
EEG is falsely lateralizing in this case due the presence 
of a large tuber in the right inferior frontal cortex ad- 
jacent to the midline. Finally, the lack of any regions 
with increased [l'C]AMT uptake in Patient 9, whose 
seizures were medically controlled at the time of the 
[ "CIAMT PET scan, suggests that the biochemical 
changes in epileptogenic tubers resulting in increased 
["CIAMT may be reversible with seizure control. 
Role of 5HT in Epilepsy 
There are several lines of evidence implicating seroto- 
nergic mechanisms as playing a role in epileptogenesis. 
In the genetically epilepsy-prone rat model of general- 
ized epilepsy, there is a decrease in brain concentration 
of 5HT,50 as well as decreased V, for [3H]5HT up- 
take by synaptosomes and tryptophan hydroxylase ac- 
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t i ~ i t y . ~ '  Pharmacological treatments that facilitate sero- 
tonergic neurotransmission inhibit seizures in many 
animal models of epilepsy, including the genetically 
epiiepsy-prone rat, maximal electroshock model, pen- 
tylenetetrazol administration, kindling, and bicuculline 
microinjections in the area tempesta~.~'  Conversely, 
the lowering of brain 5HT concentrations leads to an 
increase in seizure susceptibility in animal models of 
e p i l e p ~ y ~ ~ , ~ ~  as well as in  human^.^^.^^ Finally, in hu- 
man brain tissue surgically removed for seizure control, 
levels of 5 - H I M  (5-hydroxyindole acetic acid, the 
breakdown product of 5HT) were found to be higher 
in actively spiking temporal cortex, compared with 
normal Increased 5HT immunoreactivity 
has also been reported in human epileptic brain tissue 
resected for the control of epi lep~y. '~  
The data from human epileptic tissue cited above are 
consistent with the findings reported in the present 
study, as well as in non-TSC children with epilepsy,56 
which show that increased 5HT synthesis measured 
with [' 'CIAMT PET also correctly identifies epilepto- 
genic cortex as indicated by ictal scalp EEG recordings. 
Our  results, although preliminary, are encouraging and 
suggest that the development of PET probes with in- 
creasing specificity for epileptogenic brain regions is 
feasible and should be a logical next step in the appli- 
cation of neuroimaging to localize epileptogenic brain 
regions. Clearly, our findings must be confirmed in a 
larger group of subjects with epilepsy and multifocal 
lesions. 
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